Adam Garsa, MD

Title(s)Associate Professor Of Clinical Radiation Oncology
SchoolKeck School of Medicine of Usc
AddressGNH 1100 N. State Street
Health Sciences Campus
Los Angeles CA 90033
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr.Garsa is an Assistant Professor of Clinical Radiation Oncology at USC Norris Cancer Hospital and USC + Los Angeles County Medical Center. He joined USC in June 2017.

    Dr. Garsa graduated with honors from Washington University in St. Louis with a Bachelor of Arts degree in biology. He received his medical degree from the University of Pittsburgh School of Medicine, and completed his residency in radiation oncology at Washington University School of Medicine. In addition, he competed a CNS radiation oncology fellowship in at the University of California San Francisco.

    After completing his clinical fellowship, Dr. Garsa was on the faculty at UCSF specializing in the treatment of head and neck, CNS, skin, and lung cancers. Dr. Garsa has presented and published multiple studies investigating advanced imaging technologies and radiation therapy techniques to allow for maximal therapeutic effect while minimizing treatment side effects.

    Clinical Expertise: Head and Neck, CNS, Skin Cancer, and SBRT

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer. Int J Radiat Oncol Biol Phys. 2023 07 01; 116(3):533-543. Caudell JJ, Torres-Saavedra PA, Rosenthal DI, Axelrod RS, Nguyen-Tan PF, Sherman EJ, Weber RS, Galvin JM, El-Naggar AK, Konski AA, Echevarria MI, Dunlap NE, Shenouda G, Singh AK, Beitler JJ, Garsa A, Bonner JA, Garden AS, Algan O, Harris J, Le QT. PMID: 36549347; PMCID: PMC10247515.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    2. Radiation Therapy for Brain Metastases: A Systematic Review. Pract Radiat Oncol. 2021 Sep-Oct; 11(5):354-365. Garsa A, Jang JK, Baxi S, Chen C, Akinniranye O, Hall O, Larkin J, Motala A, Hempel S. PMID: 34119447.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    3. Use of Salvage Surgery or Stereotactic Radiosurgery for Multiply Recurrent Skull Base Chordomas: A Single-Institution Experience and Review of the Literature. J Neurol Surg B Skull Base. 2021 Apr; 82(2):161-174. Yoo SK, Strickland BA, Zada G, Bian SX, Garsa A, Ye JC, Yu C, Weiss MH, Wrobel BB, Giannotta S, Chang EL. PMID: 33777630; PMCID: PMC7987397.
      View in: PubMed   Mentions:
    4. Bevacizumab is more effective in nasopharyngeal carcinoma patients with lower maximum radiation dose to the temporal lobe. Chin Clin Oncol. 2019 Oct; 8(S1):S20. Garsa A, Ho JC, Hu C, Chang EL. PMID: 31280572.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Pretreatment metabolic tumor volume as a prognostic factor in HPV-associated oropharyngeal cancer in the context of AJCC 8th edition staging. Head Neck. 2018 10; 40(10):2280-2287. Floberg JM, DeWees TA, Chin RI, Garsa AA, Dehdashti F, Nussenbaum B, Oppelt PJ, Adkins DR, Gay HA, Thorstad WL. PMID: 30051553.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    6. Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy. J Appl Clin Med Phys. 2018 Jul; 19(4):48-57. Chapman CH, McGuinness C, Gottschalk AR, Yom SS, Garsa AA, Anwar M, Braunstein SE, Sudhyadhom A, Keall P, Descovich M. PMID: 29700954; PMCID: PMC6036380.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy. Head Neck. 2018 07; 40(7):1406-1414. Xu MJ, Lazar AA, Garsa AA, Arron ST, Ryan WR, El-Sayed IH, George JR, Algazi AP, Heaton CM, Ha PK, Yom SS. PMID: 29524273.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    8. Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension. Laryngoscope. 2018 10; 128(10):2226-2233. Yu Y, El-Sayed IH, McDermott MW, Theodosopoulos PV, van Zante A, Kased N, Glastonbury CM, Garsa AA, Yom SS. PMID: 29427378.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    9. Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer. Head Neck. 2018 05; 40(5):904-916. Zhou MJ, van Zante A, Lazar AA, Groppo ER, Garsa AA, Ryan WR, El-Sayed IH, Eisele DW, Yom SS. PMID: 29210145.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. Internal dose escalation is associated with increased local control for non-small cell lung cancer (NSCLC) brain metastases treated with stereotactic radiosurgery (SRS). Adv Radiat Oncol. 2018 Apr-Jun; 3(2):146-153. Abraham C, Garsa A, Badiyan SN, Drzymala R, Yang D, DeWees T, Tsien C, Dowling JL, Rich KM, Chicoine MR, Kim AH, Leuthardt EC, Robinson C. PMID: 29904739; PMCID: PMC6000027.
      View in: PubMed   Mentions: 15  
    11. Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy. Front Surg. 2017; 4:35. Vasudevan HN, Raleigh DR, Johnson J, Garsa AA, Theodosopoulos PV, Aghi MK, Ames C, McDermott MW, Barani IJ, Braunstein SE. PMID: 28691010; PMCID: PMC5481320.
      View in: PubMed   Mentions: 12  
    12. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck. Cancer. 2017 06 01; 123(11):2054-2060. Manyam BV, Garsa AA, Chin RI, Reddy CA, Gastman B, Thorstad W, Yom SS, Nussenbaum B, Wang SJ, Vidimos AT, Koyfman SA. PMID: 28171708.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    13. Does radiation dose matter in thyroid cancer?: Patterns of local-regional failure in recurrent and metastatic well-differentiated thyroid cancers treated with dose-painted intensity-modulated radiation therapy. J Med Imaging Radiat Oncol. 2016 Aug; 60(4):560-7. Shugard E, Chen J, Quivey JM, Glastonbury CM, Khanafshar E, Garsa AA, George JR, Yom SS. PMID: 27020481.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases. Int J Radiat Oncol Biol Phys. 2014 Oct 01; 90(2):407-13. Garsa AA, Badiyan SN, DeWees T, Simpson JR, Huang J, Drzymala RE, Barani IJ, Dowling JL, Rich KM, Chicoine MR, Kim AH, Leuthardt EC, Robinson CG. PMID: 25084610.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    15. Transperineal ultrasound-guided implantation of electromagnetic transponders in the prostatic fossa for localization and tracking during external beam radiation therapy. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):415-21. Garsa AA, Verma V, Michalski JM, Gay HA. PMID: 25407864.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    16. Outcomes of iodine-125 plaque brachytherapy for uveal melanoma with intraoperative ultrasonography and supplemental transpupillary thermotherapy. Int J Radiat Oncol Biol Phys. 2014 Mar 15; 88(4):801-5. Badiyan SN, Rao RC, Apicelli AJ, Acharya S, Verma V, Garsa AA, DeWees T, Speirs CK, Garcia-Ramirez J, Esthappan J, Grigsby PW, Harbour JW. PMID: 24462385.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    17. A prospective longitudinal clinical trial evaluating quality of life after breast-conserving surgery and high-dose-rate interstitial brachytherapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys. 2013 Dec 01; 87(5):1043-50. Garsa AA, Ferraro DJ, DeWees TA, Deshields TL, Margenthaler JA, Cyr AE, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Ochoa LL, Zoberi I. PMID: 24161428; PMCID: PMC3920547.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    18. Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma. J Radiat Oncol. 2013 Mar; 2(1):27-34. Garsa AA, Chang AJ, Dewees T, Spencer CR, Adkins DR, Dehdashti F, Gay HA, Thorstad WL. PMID: 24563726; PMCID: PMC3929054.
      View in: PubMed   Mentions: 8  
    19. Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis. Radiat Oncol. 2013 Jan 03; 8:4. Badiyan SN, Bierhals AJ, Olsen JR, Creach KM, Garsa AA, Dewees T, Bradley JD, Robinson CG. PMID: 23286648; PMCID: PMC3552761.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    20. Cosmetic analysis following breast-conserving surgery and adjuvant high-dose-rate interstitial brachytherapy for early-stage breast cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):965-70. Garsa AA, Ferraro DJ, DeWees T, Margenthaler JA, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Zoberi I. PMID: 23058060; PMCID: PMC3963512.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    21. Analysis of fat necrosis after adjuvant high-dose-rate interstitial brachytherapy for early stage breast cancer. Brachytherapy. 2013 Mar-Apr; 12(2):99-106. Garsa AA, Ferraro DJ, Dewees T, Margenthaler JA, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Zoberi I. PMID: 22726878; PMCID: PMC3929056.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    22. Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation. Radiat Oncol. 2012 Mar 29; 7:53. Ferraro DJ, Garsa AA, DeWees TA, Margenthaler JA, Naughton M, Aft R, Gillanders WE, Eberlein T, Matesa MA, Zoberi I. PMID: 22458887; PMCID: PMC3359280.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    23. Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes. Pharmacogenomics. 2008 Oct; 9(10):1403-17. Cresci S, Jones PG, Sucharov CC, Marsh S, Lanfear DE, Garsa A, Courtois M, Weinheimer CJ, Wu J, Province MA, Kelly DP, McLeod HL, Spertus JA. PMID: 18855529; PMCID: PMC2586954.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    24. Four-dimensional computed tomography-based respiratory-gated whole-abdominal intensity-modulated radiation therapy for ovarian cancer: a feasibility study. Int J Gynecol Cancer. 2007 Jan-Feb; 17(1):55-60. Garsa AA, Andrade RS, Heron DE, Beriwal S, Kim H, Brandner E, Kuo G, Chen H, Gerszten K, Yue JN, Huq MS, Lee J, Lalonde R, Wu A. PMID: 17291232.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    25. Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel. Clin Cancer Res. 2005 Nov 15; 11(22):8097-104. Henningsson A, Marsh S, Loos WJ, Karlsson MO, Garsa A, Mross K, Mielke S, Viganò L, Locatelli A, Verweij J, Sparreboom A, McLeod HL. PMID: 16299241.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCTClinical Trials
    26. CYP3A4 and CYP3A5 genotyping by Pyrosequencing. BMC Med Genet. 2005 May 09; 6:19. Garsa AA, McLeod HL, Marsh S. PMID: 15882469; PMCID: PMC1142317.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    27. Pyrosequencing of clinically relevant polymorphisms. Methods Mol Biol. 2005; 311:97-114. Marsh S, King CR, Garsa AA, McLeod HL. PMID: 16100402.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    Adam's Networks
    Concepts (152)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (30)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.